Adults taking tirzepatide lose an average of 15 kilograms over six months while experiencing a 35% reduction in fat mass and preserving skeletal muscle. A study published in the Journal of Diabetes and Its Complications tracked 122 overweight and obese patients in Palermo, Italy, to measure real-world changes in body composition and metabolic health. Patient … Read more
Global obesity rates for women are projected to reach 60·3% by 2050, according to a recent analysis by the Global Burden of Disease group cited in a new series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes in Milan, Italy. Published in The Lancet Obstetrics, Gynaecology & … Read more
An estimated 2.5 million people in the UK rely on weight loss jabs to shed up to a fifth of their body weight, but patients who stop taking the drugs face rapid weight regain unless they follow a structured exit plan, according to recent research and health experts. A landmark study published earlier this year … Read more
Children and teens prescribed GLP-1 medications for weight loss, prediabetes, or type 2 diabetes face a 16.8% risk of being diagnosed with nutritional deficiencies within their first year of treatment, according to a study published in the journal Childhood Obesity. Researchers at Ann & Robert H. Lurie Children’s Hospital of Chicago analyzed national insurance claims … Read more
The Maldives has become the only country in the World Health Organization’s South-East Asia region to meet the United Nations target for reducing premature deaths from non-communicable diseases, achieving the milestone four years ahead of the 2030 deadline, according to the WHO. Non-communicable diseases such as cardiovascular conditions, chronic respiratory diseases, cancers, and diabetes account … Read more
According to a study by the Faculty of Sport and Health Sciences at the University of Jyväskylä, a high adolescent body mass index may be linked to accelerated biological aging in adulthood. Researchers assessed participants’ biological age and examined whether adolescent BMI was associated with the rate of biological aging, finding that genetic predisposition to … Read more
According to a study published in the Journal of Asthma and Allergy by researchers C.-T. Hung, C.-Y. An, C.-W. Suk, T.-W. Lee, and S.-H. Hung, adult patients with asthma and type 2 diabetes who use tirzepatide experience a similar risk of asthma exacerbations over a 12-month period compared to those using semaglutide. The retrospective cohort … Read more
Millions of patients taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) for type 2 diabetes and obesity face renewed clarity regarding psychiatric safety, according to a systematic review published in the journal Cureus by Quadir et al. Researchers evaluating 11 primary studies representing over 4.9 million patients found no consistent class-wide increase in neuropsychiatric risks such as … Read more
According to researchers at Wuhan University, more than 3 billion people worldwide currently suffer from obesity, a figure forecasted to exceed 4 billion by 2035. To combat weight rebound and inflammation-suppressed fat browning linked to single-agent therapies, scientists developed an adipose-targeted composite microneedle patch named LRSG-SG@MN, which co-delivers semaglutide and rosiglitazone to modulate immune response … Read more
A new nationwide Medicare pilot program launched on July 1 allows beneficiaries with drug coverage to access GLP-1 weight-loss medications for $50 a month, addressing coverage gaps for drugs like Wegovy and Zepbound that previously cost up to $1,200 out-of-pocket, according to participating clinicians and pharmacists. Medicare GLP-1 Bridge Program Details and Eligibility The nationwide … Read more